Recurrence of atrial fibrillation after switching from brand to generic atenolol.

Gallelli, Luca; Maida, Francesca; Staltari, Orietta; Rende, Pierandrea; Russo, Emilio; Caroleo, Benedetto; De Sarro, Giovambattista

Gallelli, Luca; Maida, Francesca; Staltari, Orietta; Rende, Pierandrea; Russo, Emilio; Caroleo, Benedetto; De Sarro, Giovambattista.

Afiliación

Gallelli L; Department of Health Science, University of Catanzaro, Catanzaro, Italy.
Maida F; Department of Health Science, University of Catanzaro, Catanzaro, Italy.
Staltari O; Department of Health Science, University of Catanzaro, Catanzaro, Italy.
Rende P; Department of Health Science, University of Catanzaro, Catanzaro, Italy.
Russo E; Department of Health Science, University of Catanzaro, Catanzaro, Italy.
Caroleo B; Department of Health Science, University of Catanzaro, Catanzaro, Italy.
De Sarro G; Department of Health Science, University of Catanzaro, Catanzaro, Italy.

J Pharmacol Pharmacother ; 6(1): 39-41, 2015.

Article en En | MEDLINE | ID: mdl-25709353

Palabras clave

Atenolol; atrial fibrillation; brand drug; clinical ineffectiveness; generic drug

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Pharmacol Pharmacother Año: 2015 Tipo del documento: Article País de afiliación: Italia Pais de publicación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google